Glimmer of hope: New ‘supercharged’ drug can protect nerve cells that lead to Alzheimer’s

LONDON: Scientists have developed a drug with potential to stop the breakdown of nerves and brain cells that may lead to Alzheimer’s, Parkinson’s and motor neuron disease.

Alzheimer’s disease is the most common type of dementia, which includes memory loss, confusion and problems with speech and understanding.

The drug is made up of “supercharged” vitamin A, which is found in vegetables like sprouts and carrots and miniature cabbages, the Daily Mail reported.

The study showed that vitamin A turns into a chemical called retinoic acid when broken down by the body, which is crucial for the development of the nervous system.

Glimmer of hope: New ‘supercharged’ drug can protect nerve cells that lead to Alzheimer’s
Higher levels of retinoic acid in the body could halt nerve damage and boost the number of nerve cells.

“We are moving forward with a new therapeutic which could be used to help people with Alzheimer’s disease,” Peter McCaffery, lead author and Professor from the Aberdeen University in Scotland, was quoted as saying.

“Our work is still at an early stage but we believe this is a positive development and the new drugs seem to protect nerve cells” he added.

With vitamin A making a difference, it is important to find ways of tackling neurological conditions, McCaffery said.

In addition, the drug may also benefit ALS or Lou Gehrig’s disease, which affects the muscles of the arms, legs, mouth and respiratory system.

  • Related Posts

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    New Delhi — In a significant move to bring greater transparency and accountability in healthcare delivery, the Centre has directed all states and Union Territories to tighten regulatory oversight within…

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid